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Purified RPLs were immobilised on cyanogen bromide-
and epoxy-activated Sepharose beads via intrinsic lysine
residues. Commercially available lectins were also
immobilised on sepharose beads to produce columns for
comparison.
Lectin Resin 
Volume 
Total Protein 
Added
Total Protein 
Bound
Immobilisation
Density
(mL) (mg) (mg) (mg.mL-1) (mmol.mL-1)
ECL 2 32.4 19.8 9.9 0.38
RPL-Gal2 1.5 40 39.5 26.3 1.75
RPL-Gal1ME6 2 117.0 39.6 19.8 1.42
RPL-Gal1 MF3 1.7 40 39.2 23.0 1.64
RPL-Man1 2 30 30 15.0 1.1 5
2. Preparation of Lectin-Affinity Resins
AIMS:
A selection of prokaryotic lectins with a variety of glycan specificities and affinities
have been identified, cloned, expressed in Eschericia coli and characterised. The
aims of this project are to:
 express the lectins at 1L scale to produce sufficient quantities for
immobilisation studies (~100 mg)
 immobilise the lectins on Sepharose
 evaluate lectin performance on column by monitoring their ability to
reproducibly capture and elute glycoprotein glycoforms.
Recombinant bacterial lectins (RPL’s) with binding specificities for galactose (RPL-
Gal) and mannose (RPL-Man) were chosen for immobilisation experiments.
Genetically incorporated affinity tags facilitate rapid downstream purification and
provide products of consistent quality.
1. Scaled Production of RPLs
RPL-Gal2
Figure 1: Single step
purification of RPL-Gal2 by
IMAC. Approximately 150 mg
RPL-Gal2 can be recovered
from 1 L culture.
4. Project outputs
Commercialisation Activity
 This work is encompassed in a patent application which is in
preparation.
 Publication will be withheld pending patent submission.
 An Enterprise Ireland Commercialisation grant has been awarded to Dr
Paul Clarke to commercialise this research: CF 2011 1052 “ProLegere
– Glycoseparation Solutions for the Life Science Industries”
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3. Evaluation of Lectin-Affinity Resins: determination of load capacity, reproducibility and optimal elution conditions
Figure 2: Load capacity experiments established that 6 mg of asialofetuin
can be injected onto an RPL-Gal2 column without overloading the column.
Figure 4: Separation of glucose oxidase glycoforms by an RPL-Man1 using
an EDTA step gradient. The RPL’s are Ca2+ dependent allowing bound
species to be eluted using either EDTA or a specific sugar.
Figure 3: Repeat injections of 4 mg asialofetuin were performed on two 1
mL RPL-Gal2 prepared from different batches of lectin. Overlay plots
show good reproducibility between columns and excellent reproducibility
on each column (Runs1-3 & Runs4-6, respectively).
